The Boeing Company (NYSE: BA) — A Fixed Franchise Priced for a Recovery That Isn’t Finished

An independent equity research note Date: June 7, 2026 · Fiscal year referenced: FY2025 (ended December 31, 2025); Q1 2026 where noted Sector: Industrials — Aerospace & Defense · Segments: Commercial Airplanes (BCA), Defense Space & Security (BDS), Global Services (BGS) Price reference: US$215.45 (2026-06-05) · Market cap: ~US$170B · EV: ~US$200B

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The body that follows (Executive Summary through Source Appendix) deliberately takes no position, sets no price target, and carries no recommendation; that discipline is intact everywhere except here.

Verdict: HOLD at ~US$215 — a great franchise at a finished-recovery price. Not a short (the duopoly and the $682B backlog make a permanent impairment unlikely); but not a buy here either. Accumulate on a charge-driven pullback — the zone I’d want is the high-US$170s to ~US$180 (toward the SOTP midpoint, where BCA’s recovery is an option you’re not fully paying for). Directional fair-value zone ~US$200–250 if the ~$10B normalized FCF lands roughly on schedule; meaningful upside beyond requires a clean, charge-free multi-year ramp Boeing has never delivered.

The market has already done the hard work of re-rating Boeing out of its death spiral, and it has done it correctly: solvency is no longer the question. Equity is positive again, investment grade held, the DOJ criminal tail closed as a non-prosecution agreement, the FAA lifted the 737 production cap, debt fell ~$7B in a single quarter, and the company sits on a $682B backlog — roughly 7.6× revenue and a decade of demand in one of the best industry structures that exists, a global duopoly. That is a genuinely durable franchise, and BGS (the ~18%-margin services arm) is a hidden GE-Aerospace-quality jewel. But at ~$215 the stock trades at roughly 20× a ~$10B free-cash-flow target it has not earned and that is still 2–3 years out — and the “first profit since 2018” headline is an accounting mirage: it exists only because of a $9.6B gain on selling Jeppesen. Strip that out and the core still ran a ~$5B operating loss, BCA lost $7.1B, and free cash flow was negative $1.9B. You are paying a quality-compounder multiple for a business mid-repair whose single most reliable historical trait is slipping its own timeline by about a year.

That gap — a re-rated, de-risked franchise priced for an execution recovery that is far from finished — is why this is a HOLD, not a buy or a short. The framing is quality-at-a-full-price, not value; the momentum has already run (the stock is up ~50% off its 2024 lows and near the top of its 52-week range). I’d rather own the next reach-forward-charge dip than the post-recovery headline. Conviction: medium. Flips bullish on a clean, charge-free year that converts operating cash flow to a >$5B FCF run-rate with the 737 holding 52/month and the 777X actually entering service in 2027. Flips bearish on another 777X/commercial reach-forward charge or a 737 rate stall below 47/month — either would confirm the bear’s “recovery is always two years out” case and pull the multiple down hard. Two independent directors buying stock in the open market at ~$218–224 in early 2026 is a mild positive, not a thesis. Tag: “The market already fixed the franchise — buy the next charge, not the recovery headline.”

1. Executive Summary

Boeing is a structurally elite, currently sub-economic business whose survival is settled and whose recovery is real but far from finished — and whose stock, at ~$215, already prices the recovery as if it were complete.

The business. Boeing is one half of the global large-commercial-aircraft duopoly (with Airbus) and one of five US defense primes, operating through three segments: Commercial Airplanes (BCA), Defense, Space & Security (BDS), and Global Services (BGS). FY2025 revenue was a record $89,463M (+34.5%), but that follows a strike-and-grounding trough of $66.5B in 2024 — the arc ($77.8B → $66.5B → $89.5B) is recovery of self-destroyed capacity, not secular growth. The defining asset is a record $682B backlog (~7.6× revenue; >6,100 commercial aircraft) — roughly a decade of demand, the rarest thing in industrials.

The turnaround — real, but earlier and softer than the headline. FY2025 was Boeing’s first GAAP-profitable year since 2018 (+$2,235M net income) — but that profit is entirely a product of the $9,566M gain on selling Digital Aviation Solutions (Jeppesen). Strip it out and the core ran a ~$5.3B operating loss: BCA lost $7,079M (burdened by $5,283M of 777X+767 reach-forward charges), BDS was near-breakeven (−$128M), and only BGS genuinely earned money (~$3,908M underlying, ~18.7% margin). Free cash flow was −$1,877M (OCF +$1,065M less $2,942M capex) — still a burn, though a vast improvement on 2024’s −$14.3B. The recovery is visible in the trajectory (deliveries 348→600, cost-of-sales 103%→95%, debt cut to $47.2B by Q1’26, OCF burn nearly eliminated) but not yet in underlying profit or cash.

Competitive position — intact franchise, self-inflicted damage. The moat (duopoly + certification barriers + installed-base/switching-cost annuity + decade-long backlog) is one of the strongest in public markets and remains intact — no competitor breached it. But Boeing squandered its position through execution: two MAX crashes, the Jan-2024 door-plug blowout, the FAA rate cap, serial charges, and a ~60/40 narrowbody share loss to Airbus’s A320neo (now the most-delivered jetliner in history). The damage came from inside the house. Boeing still outsold Airbus on net orders in 2025 (~1,173 vs ~889) — demand for the duopoly slot is intact; the constraint is internal execution.

Balance sheet & capital allocation. Repaired, not strong: total debt $54B (down to $47.2B by Q1’26), $29B liquid + $10B revolver, equity restored to +$5.5B, IG reaffirmed one notch above junk. But the repair came via a value-dilutive ~$24B October-2024 raise at a trough price (shares 606M→762M+ plus a $5.75B mandatory convertible) and a liquidity-driven sale of the high-margin Jeppesen software jewel while reacquiring the low-margin Spirit fuselage business — crisis-management capital allocation, defensible in context but the inverse of returns-optimal. No dividend, no buyback; cash goes to deleveraging. Incentives are well-designed (bonus 80% FCF/core-EPS/revenue, 20% safety/quality).

Valuation — priced for an on-schedule recovery. P/E and EV/EBITDA are meaningless (near-zero, charge- and gain-distorted earnings). On the metrics that matter: EV ~$200B = ~2.2× FY25 sales and ~20× the ~$10B normalized-FCF target Boeing has not yet earned (FY26 guidance is only +$1–3B FCF; $10B is a 2027–28 story). A segment SOTP (BGS the premium jewel, BCA a loss-making option on execution, BDS recovering) brackets ~$130–205/share, and the current price clears it only on the bullish corners — i.e., capitalizing BCA as if its losses were already behind it. Backlog gives unmatched revenue visibility; it does not guarantee the margin and cash conversion the price embeds.

The investment question. Not solvency and not moat — both settled (it survives; it is a duopolist). It is conversion and timing: whether a structurally charge-prone manufacturer, mid-repair, converts its record backlog to ~$10B FCF on the schedule the price already discounts. The existential discount has correctly disappeared; what remains is thin cushion against Boeing’s most reliable trait — slipping the inflection by a year. This memo takes no position on that question; the body that follows is rec-free and price-target-free by design.

2. Business Overview

What Boeing is. The Boeing Company is one of two firms on earth that can design, certify, and mass-produce large commercial jet aircraft, and simultaneously one of the five US defense primes. It operates through three reportable segments — Commercial Airplanes (BCA), Defense, Space & Security (BDS), and Global Services (BGS) — plus a small captive-finance arm, Boeing Capital. In FY2025 (year ended December 31, 2025) it generated $89,463M of revenue, up 34.5% from $66,517M in FY2024, and returned to a consolidated operating profit of $4,281M after a ($10,707M) operating loss in FY2024 (FACT; FY2025 10-K segment table). This is the first GAAP profit year since 2018 and the headline evidence of a turnaround — but the composition of that profit matters enormously, as set out below.

Segment map and how each earns money.

BGS’s $13,474M includes the ~$10.55B Digital Aviation Solutions (DAS) divestiture gain (closed Oct 31, 2025); the underlying/recurring BGS operating margin is roughly 18–19% (Q4 adjusted 18.6% on $5.1B adjusted revenue) (FACT; Aviation Week MRO Memo; FY2025 10-K). Strip the gain out and the picture is stark: Boeing’s reported FY2025 consolidated operating profit of $4,281M becomes an underlying operating LOSS of roughly $6B — the “first profit since 2018” headline is an asset-sale artifact, not underlying earnings. In FY2025 Boeing’s only structurally profitable business was the aftermarket services arm.

• BCA sells new 737, 767, 777, 777X and 787 aircraft to airlines and lessors. Economics are governed by program accounting, which spreads tooling and non-recurring development costs and estimated unit costs across an accounting quantity of expected future deliveries; the 10-K explicitly notes that estimating “total revenues and cost at completion is complicated and subject to many variables,” requiring assumptions on production quantity, period, learning curve and sales prices (FACT; FY2025 10-K, critical accounting estimates). The model front-loads risk: when costs run over the accounting quantity, Boeing books reach-forward losses — the mechanism behind the multibillion-dollar charges that have repeatedly flattened earnings. BCA is the cyclical, capital-intensive, currently loss-making core; FY2025 deliveries were 600 aircraft (447x 737, 88x 787, 35x 777, 30x 767) — the most since 2018 (FACT; CNBC 2026-01-13). The 737 MAX is ramping from the FAA-imposed cap of 38/month toward internal targets of 47, then 52, then 63/month.

• BDS supplies fighters (F-15, F/A-18), the KC-46 tanker, rotorcraft (Apache, Chinook), the T-7 trainer, MQ-25, space systems and VC-25B (Air Force One). Roughly 35% of total Boeing revenue in FY2025 came from US government contracts including foreign military sales (FACT; 10-K). The crucial economic distinction is contract type: traditional cost-plus development work passes overruns to the customer, whereas Boeing’s troubled fixed-price development programs (KC-46, T-7, VC-25B, MQ-25) make Boeing eat the overrun. KC-46 alone took a fresh $565M charge in Q4 FY2025, lifting cumulative overruns to ~$9.55B (FACT; Aviation Week). BDS swung from a ($5,413M) loss in FY2024 to roughly breakeven (($128M)) in FY2025 — improvement, but still not earning.

• BGS sells parts, MRO, modifications/conversions, training, and digital/analytics to commercial and government operators across the global installed base. This is the recurring, high-margin annuity — high-teens operating margins — and the genuine quality jewel of the portfolio. Importantly, in October 2025 Boeing divested the bulk of its Digital Aviation Solutions business for $10.55B in cash, trimming BGS’s revenue base but generating a large one-time gain (FACT; 10-K).

Revenue and backlog concentration; recurring vs. cyclical vs. charge-prone. Boeing carries a record $682,207M total backlog — BCA $567,290M, BDS $84,786M, BGS $29,720M — versus $521,336M a year earlier, representing over 6,100 commercial aircraft and roughly a decade of BCA production at planned rates (FACT; 10-K backlog table). ~85% of BCA backlog is with non-US airlines, making Boeing structurally exposed to global trade policy, export controls, and currency, and to China specifically. The three segments sit on very different parts of the quality spectrum: BGS is the recurring annuity, BCA is the cyclical, capital-heavy duopoly OE business (currently loss-making but ramping), and BDS is the charge-prone government business dragged by fixed-price development. A defining FY2025 structural move was the December 8, 2025 reacquisition of Spirit AeroSystems (~$4.7B in Boeing stock plus assumed/repaid debt), re-integrating the 737/787 fuselage supplier Boeing spun off in 2005 — a deliberate reversal of two decades of outsourcing, aimed at the quality-control failures that have defined the crisis (FACT; 10-K).

Verdict. Boeing is a three-part business of radically different quality: a world-class recurring aftermarket annuity (BGS) bolted to a structurally elite but currently loss-making commercial-OE duopoly franchise (BCA) and a structurally adequate but execution-cursed defense arm (BDS). FY2025’s return to GAAP profit is real but thin and largely manufactured by the one-time DAS gain — strip it out and the underlying business still lost ~$6B at the operating line, and the only segment that consistently earns its cost of capital today is services. The economic engine that should drive the company — new-aircraft OE — is still losing money even at 600 deliveries. This is a turnaround in its early innings, resting on a backlog of unmatched visibility, not a normalized business.

3. Industry Dynamics

Commercial aerospace is one of the best industry structures in existence — a global duopoly. Large commercial aircraft is effectively a two-firm market: Boeing and Airbus, sharing essentially the entire market for narrowbody and widebody jets. The barriers to entry are about as formidable as exist in any industry: (1) type certification — a multi-year, multibillion-dollar regulatory gauntlet (FAA/EASA) that a new entrant must clear airframe-by-airframe; (2) capital intensity — a clean-sheet program costs $15–30B+ and a decade-plus to develop; (3) installed base and switching costs (covered in ); and (4) order-book visibility — Boeing alone holds a $682B backlog representing >6,100 aircraft and ~a decade of production (FACT; 10-K), with Airbus similarly sold out. Customers cannot simply switch suppliers because neither OEM has open delivery slots until the 2030s. By the Greenwald test, this is the textbook combination — economies of scale plus customer captivity plus government/regulatory intangibles — that produces durable barriers. A would-be entrant cannot reach incumbent scale because the customers are locked up for a decade and the certification/learning-curve moat cannot be bought.

Pressure-test #1 — the duopoly is not symmetric: Airbus has won. A great industry structure does not guarantee a great outcome for each incumbent, and here the duopoly has tilted decisively toward Airbus. In FY2025 Airbus delivered 793 aircraft vs Boeing’s 600 — Airbus’s seventh consecutive year out-delivering Boeing (FACT; AeroMorning; CNBC). The narrowbody segment, which is the profit engine of commercial aero (~70%+ of unit demand), has settled at roughly 60/40 in Airbus’s favor: the A320neo family carries a backlog of ~7,157 (plus 467 A220) versus the 737 MAX’s ~4,867–4,887, and the A320neo family overtook the 737 as the most-delivered jetliner in history in late 2025 (FACT; SafeFly Aviation; Forecast International). The A320neo also carries a modest 2–4% fuel-burn edge on most routes. This is share lost during Boeing’s crisis years and, critically, structurally hard to claw back: with neither OEM launching a clean-sheet narrowbody before ~the mid-2030s and both sold out for years, the current split is largely locked for this aircraft generation. The one counterweight: Boeing outsold Airbus on net orders in 2025 (~1,173 vs ~889) (FACT; CNBC), aided by a strong order tape (Emirates, etc.) — a sign demand for the franchise is intact even where share has eroded.

Pressure-test #2 — widebody. In widebody, Airbus’s A350 (>592 delivered, in service since 2015, 99.5% dispatch reliability) has become the default large twin, while Boeing’s 777X (777-9) is ~6–7 years late, with certification not expected before mid-2026 and first delivery late-2026/Q1-2027, and cumulative program charges exceeding $15B (including a $4.9B Q3 FY2025 charge) (FACT; Wikipedia; AeroXplorer; OneMileAtaTime). Some carriers have hedged the 777X delay by ordering more A350-1000s. Boeing’s 787 remains competitive in the smaller widebody class, but the flagship next-gen widebody is years behind a proven rival.

Pressure-test #3 — new entrants (COMAC). China’s COMAC C919 is the only credible new narrowbody entrant, but it remains a domestic-China product: ~16 delivered in 2025 (32 cumulative), all to Chinese carriers, with EASA certification estimated 2028–2031 and heavy dependence on Western systems (CFM LEAP engines, Honeywell/Collins avionics) that are exposed to US export controls (FACT; IBA Group; Air Data News). The C919 is a long-term structural risk to the duopoly in third markets and China’s domestic market over the next decade — it is not a near-term Western-market threat. The more immediate China risk to Boeing is geopolitical/access (~85% of BCA backlog is non-US; China has at times slowed approvals and redirected orders).

Pressure-test #4 — supply chain and regulation. The post-COVID up-cycle is supply-constrained, not demand-constrained: both OEMs are limited by engine makers (CFM/RTX), structures, and skilled labor; Boeing additionally operates under the FAA’s 38/month 737 production cap imposed after the January 2024 Alaska door-plug blowout. Regulatory overhang (FAA oversight, certification of MAX-7/MAX-10 and 777X) is an ongoing constraint that gates Boeing’s rate ramp and therefore its share-recovery path.

Defense is a structurally adequate government oligopoly with one fatal flaw. BDS competes against General Dynamics, Lockheed Martin, Northrop Grumman, RTX, and increasingly SpaceX (FACT; 10-K). The structure is a protected oligopoly — high barriers (security clearance, program incumbency, industrial base policy), a single dominant buyer (the US DoD plus allied FMS), and long program lifecycles. That is a decent structure. The flaw is fixed-price development: programs like KC-46 (cumulative ~$9.55B overrun), T-7, VC-25B and MQ-25 have been chronic value-destroyers because Boeing absorbs overruns on immature designs. The bright spot is Boeing’s March 2025 win of the NGAD/F-47 6th-generation fighter (>$20B development funding) — its first clean-sheet US fighter award in a generation, after Northrop’s 2023 exit left a two-horse race with Lockheed (FACT; ResearchAndMarkets; primaryignition.com). NGAD is a multi-decade franchise prize, but it reintroduces precisely the development-program execution risk that has bled BDS.

Capital-cycle location (Marathon). Commercial aero sits in a favorable, mid-up-cycle position: demand exceeds supply, backlogs are at records, supply additions are lumpy and lagging (rate ramps gated by certification, supply chain, labor), and pricing/discipline is firm in a two-player market. This is the kind of supply-constrained set-up where Marathon would say high valuations can be justified — but with a crucial caveat: the up-cycle’s spoils have accrued disproportionately to Airbus, because Boeing has been unable to convert backlog into deliveries at competitive rates. Defense is a more politically-driven, less classic capital cycle (state-protected — Marathon’s “capital cycle breakdown” via policymaker intervention applies), structurally steady but with budget and contract-structure risk.

Verdict: structurally excellent industry (commercial), tilted against the incumbent we’re analyzing. Commercial aerospace is among the best industry structures on the planet — an entrenched duopoly with near-insurmountable entry barriers and a decade of demand visibility — and that is unambiguously good for Boeing’s franchise value. But the structure is asymmetric in Airbus’s favor today: Boeing has ceded the profitable narrowbody to ~60/40 and is years late in widebody, so the favorable cycle has rewarded its rival more. Defense is a structurally adequate protected oligopoly undermined by self-inflicted fixed-price-development losses. Net: a great industry, a damaged position within it, and a long but credible runway to recovery given the backlog.

4. Competitive Position

Name the moat (Greenwald). Boeing’s competitive advantage is a layered combination of the three genuine advantage types — and it is one of the more durable moats in the equity universe at the franchise level:

1. Economies of scale + customer captivity (Greenwald’s strongest, most durable form): commercial aircraft has enormous fixed development and certification costs spread over long production runs; only Boeing and Airbus hold the share necessary to amortize them. Crucially, that scale is protected by captivity — customers cannot defect en masse, so an entrant cannot reach incumbent scale.

2. Customer captivity / switching costs — the real annuity engine. An airline that operates a 737 fleet is locked in by fleet commonality (spares, tooling, maintenance procedures), pilot type-ratings (retraining to a different airframe is costly and slow), and the MRO/parts ecosystem that BGS monetizes for decades after delivery. Switching to Airbus means re-training pilots and mechanics, re-tooling maintenance, and running a mixed fleet — a multi-hundred-million-dollar friction. This captivity is what gives BGS its high-teens margins on a ~$21B revenue base: every aircraft delivered is a 20–30-year aftermarket annuity (FACT; 10-K; Aviation Week MRO Memo).

3. Intangibles / regulatory + installed base — type certification is a government-granted barrier; the ~$567B BCA backlog / >6,100 aircraft is a decade of contracted demand; and the global installed base of in-service Boeing aircraft feeds BGS regardless of new-build cyclicality.

This is a high-quality moat. The market-share-stability test (Greenwald) is passed at the industry level — the Boeing/Airbus duopoly has been a stable two-firm structure for decades, with no successful entry — and the moat is clearly tied to financial outcomes (the BGS annuity would not exist without the installed-base lock-in).

The critical distinction: an intact franchise that management has squandered. Here is where rigor is essential. The moat is structurally intact, but Boeing has self-inflicted enormous damage on its competitive position through execution and safety failures: two 737 MAX crashes (2018/2019) and a 20-month grounding; the January 2024 Alaska 737-9 door-plug blowout that triggered the FAA’s 38/month production cap and a leadership purge; a ~7-week ~33,000-worker IAM strike (Sep–Nov 2024); and a serial pattern of multibillion-dollar program charges (777X >$15B cumulative; KC-46 ~$9.55B). The result is the ~60/40 narrowbody share loss to Airbus and the widebody gap. In Greenwald’s terms, the barriers to entry protect the franchise from competitors, but they do not protect it from management — and Boeing’s value destruction has come from inside the house, not from a competitor breaching the moat. This is the central nuance: franchise durability is high; the incumbent’s execution against it has been catastrophic. The bull case is that a durable moat plus a fixable execution problem is a recoverable situation; the bear case is that the share and credibility losses are partly permanent for this aircraft generation.

Direct comparison vs. Airbus.

The order-vs-delivery split is the most important tell: Boeing can still sell aircraft (it outsold Airbus in 2025) but cannot yet build them profitably or fast enough. That is consistent with a damaged-but-recovering franchise rather than a broken one — demand for the duopoly slot is intact; the constraint is internal execution and the FAA rate cap.

Comparison vs. defense primes. Against Lockheed, RTX, Northrop and GD, Boeing is a middling, structurally-disadvantaged prime today — chronically dragged by fixed-price development losses that the better-managed primes have largely avoided. The NGAD/F-47 win (>$20B, March 2025) is a genuine competitive coup that re-establishes Boeing in air dominance for decades and partly offsets the KC-46/T-7 scars — but it also re-loads the development-program risk that has been BDS’s undoing.

Capital-cycle overlay (Marathon). The favorable commercial up-cycle should be a tailwind to Boeing’s moat — but the supply-side discipline that protects the duopoly’s pricing has, in practice, benefited Airbus more, because Boeing’s supply (deliveries) has been capped by its own quality failures and the FAA. The recovery thesis is essentially a bet that Boeing closes the delivery gap (38→47→52→63/month on the 737; 777X EIS) and thereby starts re-monetizing a moat that never actually disappeared.

Verdict: a durable duopoly franchise, damaged by self-inflicted execution, in early-stage recovery. Boeing possesses one of the strongest moat structures in public markets — economies of scale + customer captivity + regulatory intangibles, with a high-margin aftermarket annuity (BGS) as proof the moat converts to cash. That moat is intact; competitors have not breached it. The damage is management-inflicted — safety/quality failures, lost narrowbody share to a ~60/40 Airbus advantage, a years-late widebody, and serial charges. FY2025’s record orders, 600 deliveries, return to (gain-aided) profit, and the F-47 win are credible evidence the recovery is real but early. The honest verdict: a great franchise that its own management nearly destroyed and is now slowly rebuilding — durable enough to recover, damaged enough that the share and credibility losses to Airbus may prove partly permanent for this aircraft generation. The recovery is plausible, not assured; it hinges on execution (rate ramp, certification, Spirit integration), which is precisely the dimension Boeing has failed on for seven years.

5. Growth History and Forward Opportunities

Boeing’s “growth” must be read as a recovery off a self-inflicted trough, not secular acceleration. Revenue rose 34.5% in FY2025 to $89,463M, but that follows a 14.5% collapse to $66,517M in FY2024 — the lowest since the depths of COVID — caused by two internal failures: the January 2024 737-9 Alaska Airlines door-plug blowout (production cap, FAA scrutiny) and the August-November 2024 IAM District 751 strike that halted Pacific-Northwest assembly. FY2023 revenue was $77,794M. So the three-year arc is $77.8B → $66.5B → $89.5B: the 2025 “record” is the system clawing back lost deliveries, not new structural demand. The honest baseline is delivery volume.

Deliveries. Total commercial deliveries were 600 in FY2025, up from 348 in FY2024 and 528 in FY2023, by program (net of intercompany): 737 — 447; 787 — 88; 777 — 35; 767 — 30. The 737 is the engine: it nearly doubled from 265 (2024) to 447 (2025). Q1 2026 delivered 143 aircraft (114 of them 737s) versus 130 in Q1 2025 — implying a 737 run-rate around 38/month early in the quarter and climbing. This is the single most important operating metric for Boeing, because each commercial program uses program accounting where margin is recognized on delivery.

Backlog and visibility. Total backlog grew $160.9B in 2025 to $682,207M (BCA $567,290M; BDS $84,786M; BGS $29,720M), and rose further to ~$694.4B at March 31, 2026. BCA backlog alone is ~13.7x FY2025 BCA revenue — extraordinary multi-year visibility, the genuine strength of the story. Book-to-bill was sharply >1 in 2025. But the backlog is gross-padded: FY2025 ASC 606 adjustments removed $17,759M (mostly 777X/787 where customer-controlled contingencies or payment probability fail the standard) and cancellations were $11,094M. “Backlog” is a demand ceiling, not a contracted-cash certainty.

Forward drivers — all supply-side, all FAA-gated:

• 737 MAX rate. Recovered from <38/mo (early 2025) to 42/mo by Q4 2025, with FAA concurrence in October 2025. Plan: 42→47 in 2026, then 47→52→63/mo with a new final assembly line (CEO Ortberg confirmed the 63/mo target and a July 2026 line start in June 2026 commentary). Each step requires FAA KPI sign-off — this is the binding constraint, not orders.
• 787 rate. Raised 5→7/mo in 2025, started toward 8/mo in Q4; targeting 10/mo. Rework on pre-2023 aircraft completed February 2025.
• 777X. First 777-9 delivery slipped from 2025 to 2027; 777-8 freighter ~2 years later; 777-8 passenger not before 2030. The program took a $4,899M incremental reach-forward loss in 2025 and faces an unresolved engine durability issue. This is a delivery drag, not a 2026-27 growth driver.
• 737-7 / 737-10. ~35 aircraft sit in inventory awaiting certification (engine anti-ice fix); both expected to certify in 2026 — a delivery catch-up catalyst.
• BDS / BGS. Defense revenue is stabilizing (+13.9% in 2025 to $27.2B as fixed-price catch-up adjustments shrink); BGS grew 4.9% to $20.9B with strong commercial aftermarket and a 39% backlog jump.

Normalized revenue potential. At 737 ~47-52/mo, 787 ~10/mo, plus BDS/BGS organic growth and a full year of Spirit consolidation, Boeing can plausibly clear $100-110B+ revenue by ~2027-2028. The CMO (43,600 aircraft over 20 years) and IATA airline profitability support end-demand.

Verdict: High-VISIBILITY but LOW-QUALITY-of-execution growth. The demand is real, durable, and duopoly-protected — backlog gives Boeing the rarest thing in industrials, a decade of order coverage. But “growth” here is the recovery of self-destroyed capacity, throttled by the FAA and a fragile supply chain, and littered with negative-margin programs (777X). It is growth you can underwrite on the order book but not on the income statement — until rates prove out and reach-forward losses stop, the growth creates revenue, not yet profit.

6. Financial Quality

The headline — first profit since 2018 — is an accounting mirage. Boeing reported FY2025 net earnings attributable to shareholders of +$2,235M, breaking a six-year loss streak. Strip out one line — a $9,672M Gain on dispositions ($9,566M of it the Jeppesen/Digital Aviation sale to Thoma Bravo) — and the picture inverts. Operating earnings were $4,281M including that gain; ex-gain, Boeing operated at roughly a $5.3B operating loss. Boeing’s own non-GAAP “core” EPS was just $1.19, and the compensation committee, for incentive purposes, adjusted core EPS down to ($10.72) specifically to neutralize the divestiture (2026 proxy, p.55). There was no underlying profit in 2025; there was a sale.

Segment economics — only one segment makes money:

* BGS FY2025 includes the $9,566M divestiture gain; underlying BGS operating earnings ≈ $3,908M (~18.7% margin).

• BGS is the jewel — mid-to-high-teens margins (18.1% FY24, 17.4% FY23, ~18.7% underlying FY25) on ~$21B of sticky commercial aftermarket and government services. This is the segment a quality investor would own standalone. Boeing just sold its highest-margin piece of it (Jeppesen) for liquidity.
• BCA lost $7,079M in 2025 — improved only marginally from -$7,969M — burdened by $5,283M of combined 777X+767 reach-forward losses. Selling more airplanes at higher rates did not yet make BCA profitable.
• BDS reached near-breakeven (-$128M, from -$5,413M) as fixed-price development catch-up losses shrank by $5,196M; 2025 fixed-price losses were $802M (mostly KC-46A $714M) versus $5,013M in 2024 (KC-46A, T-7A, Commercial Crew, VC-25B, MQ-25). BDS is healing but its fixed-price legacy contracts remain a tail risk.

Cost of sales tells the same story: 95.2% of revenue in 2025, versus a punishing 103.0% in 2024 (selling below cost) and 90.1% in 2023. The trajectory is right; the absolute level is still well above a healthy aerospace prime.

Free cash flow — the metric that actually matters. Boeing is a cash-conversion story, and on the only definition that counts (OCF − capex) it still burned cash in 2025:

FY2024’s ~$14B FCF outflow was catastrophic; 2025 narrowed the burn to ~$1.9B (Boeing’s own adjusted figure was ($1.9B), revised to ($0.5B) for incentive purposes after divestiture/Spirit normalization). Q1 2026 burned ~$1.5B — Boeing’s seasonally weakest quarter, but an improvement on Q1’25’s ~$2.3B. The cumulative 2019-2024 FCF burn ran well into the tens of billions (FY2024 alone -$14.3B), which is precisely why the balance sheet had to be rebuilt with equity. The historical ~$10B FCF target is the bull’s prize; on this trajectory it is a 2027-2028+ proposition contingent on 737 reaching ~50/mo and 787 reaching 10/mo with reach-forward losses behind it.

Balance sheet — repaired, not strong. At 12/31/2025: total debt $54,098M ($8,461M current), cash $10,921M plus short-term investments $18,479M = $29.4B liquid, plus $10.0B undrawn revolver. Net debt (against cash + ST investments) is ~$24.7B; against cash only, ~$43.2B. Maturities are laddered ($8.35B 2026, $4.40B 2027, $2.74B 2028, $2.51B 2029, $5.27B 2030), payable from cash on hand. Equity was restored to +$5,454M from a -$3,908M deficit (FY24) and a yawning -$17,233M (FY23) — but note this positive equity is partly manufactured by the Oct-2024 raise and the Jeppesen gain, not by retained operating earnings. Pension is $4.3B underfunded (GAAP) but >90% funded on an ERISA basis with no material 2026 contribution expected — a tailwind versus prior fears. Investment grade was reaffirmed and stabilized at all three agencies in 2025 (Fitch BBB-/stable, S&P BBB-/stable, Moody’s Baa3/stable) — Boeing sits one notch above junk, the thinnest possible IG margin.

Quality-of-earnings flags (material):

1. GAAP profit is a divestiture artifact — exclude the $9.57B Jeppesen gain and Boeing lost money operationally.
2. Reach-forward / forward-loss reserves — $5,283M of 777X+767 charges in 2025; the 777X took a further $4,899M loss and remains exposed to additional charges (engine issue, certification, rate changes).
3. Deferred production costs embedded in inventory: 787 $13,859M and 737 $11,777M of costs already spent that are recoverable only if future units hit target cost. If rates or learning disappoint, these convert to charges. Total inventory $84,679M (commercial programs $70,785M).
4. Net income vs OCF divergence — net income +$2.2B but OCF only +$1.1B and FCF -$1.9B; the profit did not convert to cash.

Verdict: Economics are IMPROVING with rate/scale but are NOT yet sound. Every leading indicator points the right way — cost-of-sales ratio falling, BDS catch-up losses collapsing, OCF swinging $13.1B positive, equity restored, IG held. But the business still loses money operationally ex-BGS, still burns free cash, and still carries $25B+ of deferred production and a negative-margin 777X program. This is a distressed credit convalescing, not a quality compounder. Economics will improve with scale if the FAA-gated rate ramp holds and the reach-forward losses stop — neither is yet proven.

7. Capital Allocation

Boeing’s capital allocation over the analysis window was dictated by survival, not optimization — and must be judged on that basis. The defining act was the October 2024 ~$24B capital raise: $18,200M of common stock (net) plus $5,657M of 6.00% Series A mandatory convertible preferred (net), executed near a multi-year share-price low (~$150-160). It was necessary — Boeing was bleeding $14B of FCF, carried negative equity of -$3.9B, and risked losing investment grade — but it was deeply value-dilutive, issued at a trough. Diluted weighted-average shares ballooned from 605.8M (2023) to 646.9M (2024) to 762.3M (2025), with a further ~22.98M issued in December 2025 for Spirit, and the MCP’s ~50-57M underlying common shares still to convert (the preferred accrued $345M of dividends in 2025, of which $331M was paid in cash). Existing holders were heavily diluted at the worst possible price — the textbook penalty for letting a balance sheet deteriorate to the point of forced equity issuance.

No dividend, no buyback. The common dividend has been suspended since 2020 and there is no repurchase program; management has been explicit that neither resumes until investment grade is secure and sustainable FCF returns. Capital priority is de-leveraging — net debt repayments were -$3,456M in 2025 (new borrowings $165M vs repayments $3,621M). This is the correct sequencing for a one-notch-above-junk credit: cash goes to the balance sheet before shareholders. There is no shareholder return to evaluate; the question is whether the cash that will eventually free up gets allocated well.

M&A — two large, opposite-direction deals in late 2025:

• Spirit AeroSystems reacquisition (12/8/2025), $8,371M total consideration ($4,704M Boeing stock + $2,571M settlement of loans/advances Boeing had already extended + $948M Spirit debt repaid + $109M note premium + $39M awards), generating $9,997M of goodwill assigned to BCA and ~15,000 employees. This is vertical re-integration of the 737/787/767/777 fuselage and structures supply chain — a control-and-quality deal, not a returns deal. Boeing spun Spirit off in 2005 to cut cost; the door-plug debacle exposed that outsourcing fuselage quality was a strategic error. Reacquiring it is defensible (Boeing now controls the production system the FAA scrutinizes), but it absorbs Spirit’s $3,279M of debt, a money-losing operation, and integration risk — at the bottom of Boeing’s own financial cycle.
• Digital Aviation Solutions divestiture (10/31/2025), $10,550M cash to Thoma Bravo, booking the $9,566M gain. Boeing sold Jeppesen/ForeFlight/AerData — a high-margin, capital-light software franchise inside its best segment (BGS) — to raise liquidity and de-lever. From a pure quality standpoint this is the wrong asset to sell: software multiples are richer and stickier than airframe assembly. It was a liquidity-for-quality trade, justified only by balance-sheet urgency.

The net 2025 M&A posture — buy back a low-margin fuselage maker, sell a high-margin software business — is the inverse of what a returns-focused allocator would choose in a vacuum, and is comprehensible only as crisis management.

R&D and the strategic gap. R&D was $3,615M in 2025 (BCA $2,202M, BDS $877M, BGS $125M, Other $411M) — down $197M YoY and modest for a company of this scale. No clean-sheet aircraft is funded. Boeing has not launched a next-generation narrowbody to answer the Airbus A320neo family, and the cash crisis has pushed that decision out. This is the single largest strategic capital-allocation question: the longer Boeing defers a new narrowbody, the more it cedes the heart of the market — but launching one would consume $20B+ of capital Boeing does not yet have. Management is correctly prioritizing survival over the next program, but the clock is running.

SBC and incentive alignment. SBC was $427M in 2025; executives received premium-priced options (120%-of-fair-value strike) in February 2025 — a shareholder-friendly structure that only pays if the stock appreciates 20%+. The incentive design is the most encouraging element: the 2026 proxy’s “One Company Score” ties annual bonuses (for executives and 100,000+ employees) 80% to financial targets — free cash flow, core EPS, and revenue — and 20% to safety/quality KPIs (notice-of-escape rework hours, supplier shortages, rework hours per airplane, recordable injury rate). The 2025 score was 131%, and individual NEO scores were all set at 100% (no discretionary inflation). Putting free cash flow and safety explicitly in the bonus formula is exactly the alignment this situation demands — though a 131% payout in a year of negative FCF and an operating loss ex-divestiture is a fair governance critique.

Marathon / capital-cycle lens. Boeing is a textbook capital-cycle trough: the dominant supply-side player has slashed/frozen capacity, raised emergency equity at a depressed price, deferred new programs, and operates in a structurally short, duopoly-protected market where demand (backlog) vastly exceeds supply. Marathon’s framework says high returns will be attracted back as Boeing rebuilds — the supply side is repairing precisely when demand is strongest. The capital-allocation actions (dilution, de-lever, deferred capex/programs) are what a distressed incumbent at cycle-bottom does; they destroyed near-term per-share value but were largely forced.

Verdict: Capital allocation was POOR in outcome but largely DEFENSIBLE in context — with two genuine criticisms. Management did not choose to dilute heavily, suspend returns, or sell its best software asset; the prior decade of self-inflicted operational failures forced these moves, and the sequencing (de-lever first, no premature returns) is correct. The two real critiques: (1) Boeing let the balance sheet deteriorate to the point that ~$24B of trough-priced equity and a fire-sale of Jeppesen became necessary — a capital-allocation failure that predates the current fix; and (2) the absence of a funded next-narrowbody is a strategic capital decision deferred under duress, not resolved. The incentive realignment around FCF and safety is the most credible positive. This is a management team allocating capital competently inside a crisis it inherited — not yet an allocator creating shareholder value.

7a. Filings & Insider Sweep (36-month corpus)

The trailing 36-month SEC corpus comprises 257 Form 4s, 38 8-Ks, and 3 DEF 14As. The 8-K material-event timeline maps the recovery: 7/1/2024 (Spirit merger agreement signed); 10/30-31/2024 (the ~$24B common + mandatory-convertible capital raise); 6/4/2025 and 10/29/2025 (rate-milestone/earnings disclosures, including FAA concurrence on the 42/mo 737 rate); 12/3/2025 (Digital Aviation/Jeppesen divestiture close, $10.55B) and 12/8/2025 (Spirit AeroSystems acquisition close, $8.37B) — the two transactions that drove the FY2025 GAAP profit and the equity restoration; and 1/27/2026 / 4/22/2026 (FY25 and Q1’26 earnings). One-time items distorting run-rate are concentrated and large: the $9,566M Jeppesen gain (the sole reason GAAP net income is positive), $5,283M of 777X+767 reach-forward losses, $802M of BDS fixed-price charges (KC-46A $714M), and $445M of DOJ-agreement charges (vs $244M in 2024) — all of which must be normalized out before any valuation conclusion.

The insider-transaction read is mildly constructive but not a conviction signal. Officer Form 4 activity is overwhelmingly routine: code F (shares withheld for taxes on RSU vesting — e.g., Shockey 4,444 sh, Cleary, Deasy, Gerry, Amuluru) and occasional code S sales (Amuluru/CHRO 1,503 sh), with no officer open-market buying. The only discretionary open-market purchases (code P, no 10b5-1 plan) in the window are by independent directors: Bradley Tilden bought 1,370 shares at $218.50 on 5/22/2026 (~$299K) and Mortimer Buckley bought 2,230 shares at $224.20 on 3/5/2026 (~$500K). Director open-market buys are the highest-signal insider transaction type and these are genuine, but the dollar amounts are modest and confined to two board members — a green flag, not a stampede. Notably, neither CEO Ortberg nor CFO West appears as a discretionary open-market buyer in the corpus; their holdings build through grants. Net read: insiders are aligned via equity grants and a FCF/safety-weighted bonus, two directors are putting personal cash in at ~$218-224, and no insider is signaling distress through heavy selling.

8. Major Changes — Last Two Years

The last 24 months are the most consequential in Boeing’s modern history: a near-death liquidity episode, a CEO change, a forced vertical re-integration, a criminal-case resolution, and the first signs of an operating inflection. The thesis question is whether these changes are structural repairs that compound into the ~$10B free-cash-flow (FCF) target, or one-time patches that leave a charge-prone, debt-laden business priced as if the repair were finished.

1. Leadership reset and a new operating cadence. Kelly Ortberg took over as CEO in August 2024 and has run a visibly different playbook: KPI-gated FAA rate increases, a “safety management system” framing, and conservative public guidance (under-promising on rate and FCF). The FY2025 results and the disciplined 38→42/mo recovery are the first tangible evidence the cadence is working. Interpretation: Ortberg credibility is now a real (if intangible) asset, but management commentary remains a hypothesis — the same company guided “$10B FCF” repeatedly across prior regimes and missed.

2. The October 2024 capital raise — survival at the cost of dilution. Facing the IAM 751 strike, a depleted balance sheet, and negative equity, Boeing raised ~$24B in October 2024 via common stock plus a 6.00% Series A mandatory convertible preferred (~$5.75B liquidation preference, converting to common ~October 2027). This averted a downgrade to junk and restored equity to +$5.5B by YE2025 (from −$3.9B YE2024, −$17.2B YE2023). Interpretation: a genuine de-risking — but the cure was permanent dilution. Common shares are ~788M and full conversion of the mandatory convertible adds another ~25-30M, so per-share recovery math is structurally diluted versus the pre-crisis ~600M share count.

3. The Spirit AeroSystems reacquisition (closed Dec 8, 2025). Boeing paid $8.37B total consideration ($4.7B equity + ~$2.6B funding incl. Spirit’s settlement payment to Airbus + $0.95B debt repaid) to re-internalize the fuselage supplier whose defects (notably the 737-9 door plug) repeatedly halted Boeing’s lines. Airbus simultaneously absorbed Spirit’s Airbus-program plants and received ~$439M. Interpretation: strategically defensible — Boeing cannot run a stable 737/787 line through a supplier it does not control — but it internalizes a chronically loss-making operation, guided at ~$1B/yr cash drag in 2026–27, and is the proximate reason BCA’s return to profit slipped to 2027.

4. The DOJ MAX criminal case resolved as a non-prosecution agreement (not a plea). On May 29, 2025 Boeing and DOJ replaced the breached January-2021 deferred-prosecution agreement with a non-prosecution agreement: $244M fine + $445M family fund ($689M escrowed). The district court dismissed the criminal information (Nov 6, 2025); the Fifth Circuit upheld dismissal (Mar 31, 2026); families’ en-banc petition is pending. Interpretation: the catastrophic “felon-contractor / debarment” tail risk that would have threatened the BDS franchise is now substantially closed, though not litigation-final.

5. Digital Aviation Solutions divestiture (Oct 2025). Boeing sold DAS/Jeppesen to Thoma Bravo for ~$10.6B, booking a $9,566M pre-tax gain that single-handedly produced BGS’s reported FY25 segment earnings of $13.5B and the consolidated GAAP profit. Interpretation: a clean deleveraging move and a good price — but it also sold a high-margin, high-multiple software asset, and it inflates the FY25 “first profit since 2018” headline that bulls cite. Normalized BGS earnings were ~$3.9B.

6. Operating inflection: rate, deliveries, deleveraging. 737 rate recovered to 42/mo with the FAA cap removed in early 2026 and 47/mo approved (May 27, 2026); 787 climbed to 8/mo (toward 10); 600 commercial deliveries in FY2025. Q1-2026 cut total debt to $47.2B from $54.1B (−$6.9B) and OCF use to just −$0.2B. Interpretation: the most credible evidence yet that the turnaround is real and converting to cash.

7. Defense wins and China re-opening. F-47 NGAD (>$20B, 185 aircraft) and KC-46 follow-on rebuild the BDS franchise; China’s May-2026 agreement to buy ~200 jets and the June-2025 resumption of MAX deliveries re-open the single largest lost market.

Verdict — Net thesis-strengthening, but the “first profit” and “$10B FCF” headlines are softer than they appear. The structural risks (criminal tail, liquidity, supplier instability, China freeze) have all been materially reduced. But three of the most-cited positives are accounting- or one-time-flavored: the FY25 GAAP profit rests on the DAS gain; BCA still loses money; and the FCF target depends on 777X EIS and Spirit synergies that have repeatedly slipped. The changes move the thesis from “is this company solvent?” to “will the recovery convert on schedule?” — a real upgrade, but not yet a finished turnaround.

9. Risk Analysis — Risk Matrix

Boeing is a uniquely risk-laden industrial: a duopolist with a near-unbreakable demand backstop on one side, and a serial-charge, balance-sheet-impaired, regulatorily-tethered operator on the other. The matrix below weights the risks that move the normalized-FCF-conversion thesis, not the (already largely closed) existential ones.

Verdict — The existential risks are now tail risks; the thesis risk is timing and charge-recurrence. Bankruptcy/debarment risk has fallen sharply (capital raise, NPA, DAS proceeds, deleveraging). What remains is a high-likelihood, recurring pattern of program charges and rate/cert slippage that pushes the FCF inflection out a year at a time. The backlog and duopoly make a permanent impairment unlikely; they do not protect against the recovery arriving slower and cash-lighter than the price embeds.

10. Valuation — Embedded Expectations

P/E and EV/EBITDA are uninformative for Boeing today: core earnings are at/near zero, distorted by reach-forward charges and the DAS gain, and equity was negative until FY2025. We value on EV/Sales, normalized FCF, SOTP, and backlog coverage, and then reverse-engineer what the ~$215 price requires.

Setup. At ~$215/sh and ~788M common shares, market cap ≈ $170B. Adding net debt (~$47.2B debt − ~$20.9B cash/short-term investments ≈ $26B net) and the ~$5.75B mandatory-convertible preferred gives EV ≈ $199–202B. On FY2025 revenue of $89.5B, that is EV/Sales ≈ 2.2x — above Airbus (~1.5–1.8x) and rich for a business whose largest segment still loses money, but below pure-play growth/services peers (GE Aerospace, TransDigm).

1. Normalized FCF — the multiple the market is actually paying

Management’s stated through-cycle target is ~$10B FCF. Against an EV of ~$200B, $10B FCF ≈ 20x EV/normalized-FCF (≈ a 5% normalized FCF yield to EV). That is a full-recovery, quality-compounder multiple — roughly in line with where high-quality aerospace franchises trade — applied to FCF Boeing has not yet earned and that depends on a stack of assumptions all going right:

• 737 MAX at 47→52/mo (~500+ deliveries/yr) with 737-7/-10 certified;
• 787 at 8→10/mo;
• 777X EIS in 2027 with no further reach-forward;
• BDS to high-single-digit margin from ~0%; BGS holding ~18%;
• Spirit synergies overcoming the ~$1B/yr drag;
• no new commercial program charge.

Embedded expectation: the market is already paying for the substantially completed recovery. FY2026 guidance is only +$1B to +$3B FCF; bridging to $10B is a 2027–2028 story. So at ~20x, the price discounts not just that Boeing hits $10B, but that it does so reasonably on schedule and then grows it — leaving little margin of safety if the inflection slips another year (its modal historical outcome).

2. Sum-of-the-Parts (illustrative, to locate where the value sits)

SOTP is the more honest lens because the three segments deserve different multiples and Boeing’s consolidated metrics are distorted.

Interpretation: the SOTP midpoint brackets the ~$215 price but only the bullish corners (BCA normalizing at a full multiple + premium BGS) clear it comfortably. The current price effectively capitalizes BCA as if its losses were already behind it. BGS is the asset a strategic buyer would covet; BCA is the option on execution.

3. EV/Sales vs. history and peers; backlog coverage

EV/Sales ~2.2x sits above Boeing’s own pre-crisis range and above Airbus — defensible only on the thesis that revenue is depressed (delivery-constrained, not demand-constrained) and margins are about to inflate. Backlog of $682B = ~7.6x revenue is the strongest single bull data point: it removes demand risk for the better part of a decade and makes revenue growth a production question, not a market question. Peer marks for context (not applied as targets): RTX ~18-20x P/E; GE Aerospace ~37-40x P/E / ~24x EV/EBITDA; TransDigm ~32-40x; Safran ~27x; LMT/GD ~15-18x P/E; Airbus the duopoly comp at lower EV/Sales but positive margins.

Verdict — Priced for a successful, on-schedule recovery; thin margin of safety. On every framework, today’s EV embeds Boeing earning roughly its full ~$10B normalized FCF and the SOTP requires BCA to normalize. The valuation is not absurd — the duopoly, $682B backlog, and BGS quality justify a premium-to-Airbus EV/Sales — but it is not cheap on anything except a normalized base the company has yet to reach. The market is underwriting the recovery’s completion and timeliness; the open question is whether ~20x FCF leaves enough cushion for Boeing’s well-documented tendency to slip the inflection by a year.

11. Variant Perception

Consensus view. The recovery is on track and de-risked: 737 cap removed and rate climbing to 47/mo, debt falling fast, equity restored, criminal tail closed, record backlog, Ortberg credible — and the ~$10B FCF target is a matter of when, not if. Consensus treats Boeing as a quality-compounder-in-recovery and is comfortable paying ~20x normalized FCF for a duopoly franchise.

The strongest bull case. Boeing is one half of an unbreakable global duopoly with a $682B backlog (~7.6x revenue) — demand is essentially guaranteed for a decade; the only question is production. The operating evidence is now real, not promised: FY25 record deliveries, debt cut $6.9B in a single quarter, OCF use nearly eliminated, FAA cap removed. BGS is a ~18%-margin, GE-Aero/TransDigm-quality services business hiding inside a battered conglomerate. Defense is rebuilding (F-47, KC-46) and China just re-opened (~200 jets). As 737 hits 52/mo, 787 hits 10, 777X enters service, and Spirit synergies land, FCF inflects toward $10B and the balance sheet de-levers — and the equity, still off its highs and diluted to a recovery-trough base, re-rates as the charges stop. Falsification: a single year of clean, charge-free deliveries at rate, converting OCF to >$5B FCF run-rate, would validate the bull.

The strongest bear case. Boeing is priced for perfection on a recovery that is perpetually “two years out.” The ~$10B FCF target has been promised across multiple CEOs and repeatedly missed; the company took $5.3B of fresh 777X/767 charges in FY2025 alone and the 10-K explicitly warns of more. The “first profit since 2018” is an artifact of a $9.6B asset-sale gain — BCA, the core, still lost $7.1B. The 777X is ~7 years late with a new engine durability problem; Spirit is a ~$1B/yr cash sink Boeing chose to swallow; debt is $47B at the lowest investment-grade notch; and the share count is permanently inflated by the rescue raise plus a ~$5.75B convertible. At ~20x a normalized FCF it hasn’t earned, the stock has negative margin of safety against its own modal outcome — another year’s slip. Falsification: another reach-forward charge, a 777X slip past 2027, or 737 rate stalling below 47/mo would confirm the bear.

The 3–5 assumptions that actually matter:

1. Does 737 reach and hold ~52/mo with 737-7/-10 certified? This is ~60% of the FCF bridge.
2. Does 777X enter service in 2027 with no further reach-forward charge? The single biggest charge-recurrence risk.
3. Does Spirit become a synergy source, or a permanent ~$1B/yr drag that caps FCF below $10B?
4. Does BCA actually turn operating-profitable (vs. the −$7.1B FY25), and on what timeline?
5. Does BGS’s ~18% margin hold post-DAS divestiture, justifying the SOTP’s highest-multiple piece?

Where the variant perception lives. The genuine debate is not solvency or moat (both settled: it survives; it is a duopolist). It is conversion and timing — whether a structurally charge-prone manufacturer, mid-repair, converts its record backlog to ~$10B FCF on the schedule the price embeds. Bulls extrapolate the Q4-25/Q1-26 inflection linearly to $10B; bears note Boeing has never once delivered a clean, charge-free recovery year and is being asked to deliver several consecutively while integrating Spirit and certifying two aircraft. Verdict: the asymmetry is unusual — the business-quality tail risk (debarment, insolvency, moat loss) has largely closed, while the valuation offers little cushion for the execution-timing risk that is Boeing’s most reliable historical trait. The market has correctly re-rated away the existential discount; the open question is whether it has now over-priced the timeliness of a recovery that has slipped, on average, about once a year.

12. Fact vs. Interpretation Table

13. Open Questions

1. Does the 737 reach and hold ~52/month with the 737-7/-10 certified? This is ~60% of the FCF bridge; ~35 uncertified -7/-10 sit in inventory.
2. Does the 777X enter service in 2027 with no further reach-forward charge? The single biggest charge-recurrence risk; a new GE9X engine durability issue is unresolved.
3. Will the deferred production balances (787 $13.9B, 737 $11.8B) be recovered at target cost, or convert to charges if rates/learning disappoint?
4. Does Spirit become a synergy source or a permanent ~$1B/yr cash drag that caps FCF below $10B?
5. Does BGS’s ~18% margin hold post-Jeppesen divestiture, justifying the SOTP’s highest-multiple piece?
6. When does Boeing launch a clean-sheet next-gen narrowbody, and what $20B+ capex/FCF hit does it carry? The longer it defers, the more it cedes to Airbus.
7. Can BDS sustain its return toward high-single-digit margins without new fixed-price-development charges (KC-46, T-7, MQ-25, and now the F-47)?
8. How durable is the China re-opening (~200-jet May-2026 deal), which is reversible on tariffs/politics, and the ~$7B Middle East delivery exposure?

14. What Must Be True (Bull vs. Bear, each with a falsification test)

For the BULL case to be right (the recovery converts and the franchise re-rates):

1. The 737 reaches and holds ~52/month with the 737-7/-10 certified, lifting deliveries to ~500+/year.
2. The 777X enters service in 2027 with no further reach-forward charge, and the 787 reaches 10/month.
3. BCA turns operating-profitable and BDS marches to high-single-digit margins; BGS holds ~18%.
4. Spirit synergies overcome the ~$1B/yr drag, and FCF inflects toward the ~$10B target by 2027–28, enabling deleveraging and the eventual return of capital.

Falsification test: A single clean, charge-free year that converts OCF to a >$5B FCF run-rate would validate the bull. If FCF is still below ~$3B in 2027 with the rate ramp delivered, the “$10B” base is a mirage.

For the BEAR case to be right (the cheapness of the franchise is offset by an over-priced recovery):

1. Reach-forward charges recur (777X, 767, or a new program), keeping BCA loss-making and the “$10B FCF” perpetually two years out.
2. The 737 rate stalls below ~47/month (FAA, supply chain, or a fresh quality escape), or the 777X slips past 2027.
3. Spirit proves a permanent cash sink; the deferred-production balances convert to charges.
4. The market de-rates the ~20× normalized-FCF multiple as the timeline slips, compounding the dilution overhang from the mandatory convertible.

Falsification test: Another reach-forward charge, a 777X slip past 2027, or a 737 rate stall below 47/month confirms the bear. Conversely, two consecutive clean delivery years refute it.

15. Source Appendix

A full source appendix — primary filings (FY2023–FY2025 10-Ks, the Q1 2026 10-Q, the 2026 DEF 14A, the trailing 36-month SEC corpus including 8-Ks and Form 4s), third-party industry/market-share data (Airbus deliveries, narrowbody share, COMAC), regulatory and program sources (FAA rate, 777X certification, DOJ resolution), peer valuation marks, and management call commentary — is provided as Appendix B below. Primary sources (Boeing SEC filings) are the authority for all financial figures; management transcript commentary is treated as hypothesis and validated against filings; third-party estimates (share, peer multiples) are labeled as such. P/E and EV/EBITDA were treated as uninformative (near-zero, charge/gain-distorted earnings) and the analysis anchored on EV/Sales, free cash flow, deliveries, and backlog.

APPENDIX A — Standard Diligence Questionnaire

Companion to the research note on The Boeing Company (NYSE: BA), FY2025 (ended December 31, 2025); Q1 2026 where noted. Fact / Interpretation / Assumption labels applied where they matter. $ figures in USD millions unless noted.

General

What thoughtful questions have other investors asked about this company? The serious ones: (1) Is FY2025’s “first profit since 2018” real or an artifact of the $9.6B Jeppesen-sale gain? (2) Does the 737 actually reach and hold 47→52→63/month, and do the 737-7/-10 certify? (3) Will the 777X enter service in 2027 without yet another reach-forward charge? (4) Does Boeing convert its record $682B backlog into the ~$10B free cash flow it keeps promising, and on what timeline? (5) Does the Spirit reacquisition fix the supply chain or import Spirit’s losses? (6) At ~20× unearned normalized FCF, is the recovery already priced in?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Low — a recovering trough. FY2025 revenue is a “record” only because 2024 collapsed on the door-plug grounding and the IAM strike; underlying profit and free cash flow are still negative ex-divestiture. Boeing is in the early-mid innings of a recovery, not at a cyclical peak.

Driven by the external environment or internal actions? Overwhelmingly internal. The 2024 trough was self-inflicted (quality failures, FAA cap, strike); the recovery is internally driven (rate ramp, quality fixes) within a favorable external demand environment (record backlog, strong air-travel cycle).

How stable are revenues? Demand is exceptionally stable and visible (decade-long backlog), but recognized revenue is volatile because it depends on FAA-gated production rates and program accounting. BGS (services) is the most stable; BCA the most variable.

Outlook for products/services? Strong demand across the board: 737 MAX and 787 sold out for years; 777X has 560+ orders; defense rebuilding (F-47, KC-46); BGS aftermarket growing with the installed base. The constraint is production, not demand.

How big will this market be — growing, shrinking, domestic or international? Large and structurally growing: Boeing’s CMO projects ~43,600 new aircraft over 20 years; air traffic compounds with global GDP. ~85% of BCA backlog is non-US — heavily international, with attendant trade/geopolitical exposure (China, Middle East).

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Commercial aero is a stable global duopoly (Boeing/Airbus) — not getting more competitive in the near term, though COMAC’s C919 is a long-term (2028–31+) entrant. Defense is a protected five-prime oligopoly. Within the duopoly, Airbus has gained share (~60/40 narrowbody) — a Boeing-specific position loss, not an industry-structure change.

How profitable is the business (ROIC, ROE)? Currently not profitable on a normalized basis — ROE/ROIC are meaningless (near-zero/recovering earnings, recently-negative equity). At full health, aerospace primes earn high-teens+ returns; Boeing is years from that. Only BGS earns its cost of capital today (~18.7% segment margin).

How profitable is the industry — competitors and barriers? The industry is highly profitable for well-run participants: Airbus is profitable; GE Aerospace earns ~20%+ margins / $6B+ FCF; suppliers like Howmet earn 30%+ EBITDA margins. Barriers are among the highest anywhere (type certification, $15–30B clean-sheet cost, decade-long backlogs). Boeing’s sub-par profitability is execution-specific, not industry-specific.

Can the business be easily understood? The franchise yes (a duopoly airframer + defense prime + services annuity); the accounting no — program accounting, reach-forward losses, deferred production costs, and one-time gains/charges make reported earnings hard to read. Free cash flow and deliveries are the honest metrics.

Can it be undermined by foreign low-cost labor? Not meaningfully — the barriers are certification, IP, and scale, not labor cost. The relevant long-term threat is a state-backed entrant (COMAC), not low-cost labor per se.

Do brands matter? Less than fleet economics. Airlines choose on price, fuel burn, delivery slot, commonality, and reliability. Boeing’s “brand” was damaged by the crashes/door-plug, which mattered via regulatory and airline trust, not consumer brand.

Customers’ switching costs? High — fleet commonality, pilot type-ratings, spares/tooling, and the MRO ecosystem lock operators in for decades. This captivity is precisely what powers the BGS aftermarket annuity (the moat’s clearest financial proof).

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The $682B backlog is the great off-balance-sheet asset (decade of contracted demand). Conversely, deferred production costs ($13.9B 787, $11.8B 737) are on the balance sheet in inventory but are recoverable only if future units hit target cost — a soft asset.

Off-balance-sheet liabilities? Customer/supplier financing commitments, fixed-price-development forward-loss exposure beyond booked reserves, and litigation (MAX securities/door-plug suits). Pension is on-balance-sheet, $4.3B underfunded (GAAP) but >90% funded on an ERISA basis.

How conservative is the accounting? Aggressive in structure, not in spirit. Program accounting front-loads judgment (accounting quantity, learning curves) and can defer cost recognition; but Boeing does take large reach-forward losses ($5.3B in 2025) rather than hide them. The biggest distortion is the $9.6B Jeppesen gain inflating GAAP profit — disclosed, but it makes the headline misleading.

How CapEx-hungry is the business? Moderate ongoing capex ($2.9B FY25, rising), but the real capital intensity is the working-capital/inventory build of ramping production and the periodic $15–30B clean-sheet program — the next narrowbody, currently unfunded, is the looming capital event.

Capital Allocation & Management

How much FCF does the business generate, and how is it used? Currently negative (−$1.9B FY25; −$14.3B FY24). When FCF returns, the priority is deleveraging (no dividend, no buyback until IG-secure and FCF-sustainable). The bull prize is the ~$10B FCF target (2027–28+).

Significant acquisitions recently? Yes — Spirit AeroSystems reacquired (Dec 2025, ~$8.4B), vertical re-integration of the fuselage supply chain (control/quality, not returns). Paired with the Jeppesen/DAS divestiture (Oct 2025, $10.55B).

Buying back shares? No — buyback suspended; the opposite happened: a ~$24B October-2024 equity raise diluted holders (shares 606M→762M+ plus a $5.75B mandatory convertible).

Issuing large amounts of new shares to insiders? No — SBC is modest ($427M FY25); the dilution is from the rescue capital raise, not insider grants. Executive options were struck at a 120% premium (shareholder-friendly).

Compensation policy / incentive alignment? Well-designed for the situation: the “One Company Score” ties bonuses 80% to FCF/core-EPS/revenue and 20% to safety/quality KPIs. Fair critique: a 131% payout in a year of negative FCF and an ex-gain operating loss.

Motivations of management? Ortberg (CEO since Aug 2024) is running a credible, safety-and-FCF-focused turnaround with conservative guidance — a marked change from the prior financial-engineering culture. Two independent directors bought stock in the open market (~$218–224) in early 2026; officers are net neutral-to-sellers via routine vesting.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — a straightforward US common stock (NYSE: BA), 1099 reporting.

Dividend policy? No dividend (suspended 2020); none expected until investment grade is secure and FCF is sustainably positive.

How profitable is the business? Not yet, on a normalized basis (only BGS earns money today). Reported GAAP profit is a divestiture artifact.

Is net income diverging from cash from operations? Yes, materially. FY2025 net income +$2.2B but OCF only +$1.1B and FCF −$1.9B — the “profit” did not convert to cash (it was a non-cash gain). Use FCF, not net income.

Risks & Downside

What factors would cause the stock to decline? Another reach-forward charge (777X/767/new program); a 737 rate stall below 47/month or a fresh quality escape; a 777X slip past 2027; Spirit proving a permanent cash sink; a credit downgrade to junk; a China/Middle East delivery reversal; or simple multiple de-rating as the ~$10B FCF timeline slips.

Risk of a catastrophic loss? Now lower than in 2024 — solvency is restored, IG held, the DOJ criminal tail closed. The residual catastrophic scenario is a fresh fatal accident traced to Boeing quality, which would reset the FAA relationship and re-impair the recovery narrative (low probability, high impact).

Chance of a total loss? Very low. A duopolist with a $682B backlog, positive equity, $29B liquidity, and investment grade is not a plausible zero in any normal scenario; a total loss would require a catastrophic safety/quality rupture plus a financing-market shutdown.

Recent News & Events

Has the business environment changed recently? Yes, materially and mostly favorably: the FAA removed the 737 production cap (early 2026) and approved 47/month (May 2026); debt fell to $47.2B in Q1’26; the DOJ case closed; China re-opened (~200-jet deal); and the F-47 fighter was won (Mar 2025). Offsetting: a new GE9X engine durability issue (Jan 2026) on the 777X.

Significant acquisitions? Spirit AeroSystems (Dec 2025); Jeppesen/DAS divested (Oct 2025).

Change in accounting policies? No policy change, but two large one-time items (the $9.6B Jeppesen gain; $5.3B of 777X/767 reach-forward charges) dominate FY2025 reported earnings and must be normalized.

Recent changes — new markets, facilities, management? New CEO (Ortberg, Aug 2024) and CFO; a new 737 final-assembly line (Everett North) to enable rates above 47/month; the China market re-opening; and the F-47 program re-establishing Boeing in 6th-gen fighters.

APPENDIX B — Source Appendix

Target: The Boeing Company (NYSE: BA) · FY2025 (ended December 31, 2025); Q1 2026 where noted Authority hierarchy: SEC filings (10-K / 10-Q / 8-K / DEF 14A) are primary for all financial figures. Management earnings-call commentary is treated as hypothesis and validated against filings. Third-party estimates (Airbus deliveries, narrowbody share, COMAC, peer multiples) are labeled as such. P/E and EV/EBITDA were treated as uninformative (near-zero, charge- and divestiture-gain-distorted earnings); the analysis is anchored on EV/Sales, free cash flow, deliveries, and backlog.

A. Primary sources — Boeing SEC filings (CIK 0000012927)

B. Market data (convenience data — reconciled to filings)

C. Third-party industry / market data (estimates — labeled in text)

D. Regulatory, legal & program sources

E. Management commentary

Boeing’s quarterly earnings-call transcripts (Q3-2024 through Q1-2026, publicly available via the company’s investor-relations site and public transcript providers) were used for management’s framing of the 737 rate ramp (38→42→47→52→63/month), the free-cash-flow guide (+$1–3B for FY2026, “$10B attainable” longer-term), the Spirit integration drag, the 777X 2027 entry-into-service, the Q1’26 debt reduction to $47.2B, and BDS/BGS segment margins. All such commentary is treated as management hypothesis and validated against the SEC filings; the filings are the authority for every financial figure in this note.

All figures are anchored to Boeing’s SEC filings; third-party deliveries/share and peer-multiple estimates are labeled as such in the text. The Industry and Competitive sections were built from public sources.